Similarly, the revised scheme allows integration with state government schemes, enabling units to benefit from additional top-up assistance.
This collaborative approach aims to maximise support for the pharmaceutical industry in their technology upgradation efforts, as per the statement.
The scheme also introduces a robust verification mechanism through a project management agency, ensuring transparency, accountability and the efficient allocation of resources, it added.
The revised guideline aims to support the pharmaceutical industry’s up-gradation to the Revised Schedule-M & WHO-GMP standards, enhancing the quality and safety of pharmaceutical products manufactured in the country, the ministry stated.
